目前,临床上病理医师对脑膜瘤的诊断仍依靠肿瘤所表现出的形态特征来判断其病理亚型,但脑膜瘤细胞不仅具有多种形态及其成分,且各种细胞及其成分之间有移行,部分病理易造成误诊,往往需要借助其他辅助手段。免疫组化技术把传统的病理形态学推向分子水平,这一有力的辅助工具使得许多肿瘤 Currently, clinical pathologists are still relying on the diagnosis of meningioma tumor morphology characteristics to determine its pathological subtype, but not only meningioma with a variety of morphological and its components, and a variety of cells and their components Migration, part of the pathology is likely to cause misdiagnosis, often need to use other aids. Immunohistochemical techniques to the traditional pathological morphology to the molecular level, this powerful tool enables many tumors